Studies on the metabolic fate of n-3 polyunsaturated fatty acids

被引:23
|
作者
Ferdinandusse, S
Denis, S
Dacremont, G
Wanders, RA
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, NL-1100 DE Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1100 DE Amsterdam, Netherlands
[3] Univ Ghent, Dept Pediat, B-9000 Ghent, Belgium
关键词
peroxisomes; beta-oxidation; docosahexaenoic acid; thioesterase; acyl-CoA oxidase;
D O I
10.1194/jlr.M300223-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several different processes involved in the metabolic fate of docosahexaenoic acid (DHA, C22:6n-3) and its precursor in the biosynthesis route, C24:6n-3, were studied. In cultured skin fibroblasts, the oxidation rate of [1(-14)C] 24:6n-3 was 2.7 times higher than for [1-C-14]22:6n-3, whereas [1-14C]22:6n-3 was incorporated 7 times faster into different lipid classes than was [1-14C]24:6n-3. When determining the peroxisomal acyl-CoA oxidase activity, similar specific activities for C22:6(n-3)-CoA and C24:6(n-3)-CoA were found in mouse kidney peroxisomes. Thioesterase activity was measured for both substrates in mouse kidney peroxisomes as well as mitochondria, and C22:6(n-3)-CoA was hydrolyzed 1.7 times faster than C24:6(n-3)-CoA. jlr These results imply that the preferred metabolic fate of C24:6(n-3)-CoA, after its synthesis in the endoplasmic reticulum (ER), is to move to the peroxisome, where it is beta-oxidized, producing C22:6(n-3)-CoA. This DHA-CoA then preferentially moves back, probably as free fatty acid, to the ER, where it is incorporated into membrane lipids.-Ferdinandusse, S., S. Denis, G. Dacremont, and R. J. A. Wanders. Studies on the metabolic fate of n-3 polyunsaturated fatty acids. Lipid Res. 2003. 44: 1992-1997.
引用
收藏
页码:1992 / 1997
页数:6
相关论文
共 50 条
  • [1] The biochemistry of n-3 polyunsaturated fatty acids
    Jump, DB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (11) : 8755 - 8758
  • [2] Immunomodulation by n-3 polyunsaturated fatty acids
    Netea, MG
    Kullberg, BJ
    Blok, WL
    Van der Meer, JWM
    [J]. IMMUNOLOGY TODAY, 1999, 20 (02): : 103 - 103
  • [3] n-3 polyunsaturated fatty acids and immune function
    Wu, DY
    Meydani, SN
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 1998, 57 (04) : 503 - 509
  • [4] n-3 polyunsaturated fatty acids and cardiovascular diseases
    Nordoy, A
    Marchioli, R
    Arnesen, H
    Videbæk, J
    [J]. LIPIDS, 2001, 36 : S127 - S129
  • [5] N-3 polyunsaturated fatty acids and cardiac mortality
    Singleton, CB
    Walker, BD
    Campbell, TJ
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 2000, 30 (02): : 246 - 251
  • [6] n-3 polyunsaturated fatty acids and breast cancer
    Lhuillery, C
    Cognault, S
    Germain, E
    Chajes, V
    Bougnoux, P
    [J]. BREAST CANCER - ADVANCES IN BIOLOGY AND THERAPEUTICS, 1996, : 59 - 65
  • [7] N-3 Polyunsaturated Fatty Acids and Gut Microbiota
    Jayapala, Hettiarachchige Priyanga Sajeewanie
    Lim, Sun Young
    [J]. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2023, 26 (05) : 892 - 905
  • [8] n-3 polyunsaturated fatty acids and coronary thrombosis
    Kristensen, SD
    Iversen, AMB
    Schmidt, EB
    [J]. LIPIDS, 2001, 36 : S79 - S82
  • [9] Human requirement for n-3 polyunsaturated fatty acids
    Simopoulos, AP
    [J]. POULTRY SCIENCE, 2000, 79 (07) : 961 - 970
  • [10] N-3 polyunsaturated fatty acids and brain aging
    Nyakas, C.
    Hogyes, E.
    Kacsandi, A.
    Felszeghy, K.
    Mehra, R. D.
    Luiten, P. G. M.
    [J]. ACTA PHYSIOLOGICA HUNGARICA, 2010, 97 (04) : 465 - 466